Diamedica Therapeutics (DMAC) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Diamedica Therapeutics Inc. has filed a current report with the SEC, indicating a significant event or update as of May 22, 2024. The company’s voting common shares are listed on The Nasdaq Stock Market under the ticker symbol DMAC. This report reflects the company’s continuous compliance with the regulatory requirements of the Securities Exchange Act of 1934.
For further insights into DMAC stock, check out TipRanks’ Stock Analysis page.
